W
GMED icon

WealthOne’s Globus Medical GMED Stock Holding History

WealthOne’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$252K Buy
+5,082
New +$284K 0.1% 66

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $588M AUM 6.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $3.12B AUM 53.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WealthOne's GMED Position: Q3 2023 in Review

WealthOne opened a new position in Globus Medical (GMED) in Q3 2023: 5,082 shares worth $252K. The stake represents 0.1% of the portfolio and ranks #66 among its holdings.

430 funds tracked by Wall St. Rank hold GMED as of Q3 2023.

  • WealthOne held 5,082 shares of Globus Medical worth $252K as of Q3 2023.
  • Globus Medical was a new WealthOne position in Q3 2023.
  • Globus Medical made up 0.1% of WealthOne's portfolio in Q3 2023, its #66 holding.
  • 430 funds tracked by Wall St. Rank held Globus Medical as of Q3 2023.

Based on WealthOne's 13F filing for Q3 2023, filed 12 Oct 2023.